Next |
home / stock / caba / caba message board
Subject | By | Source | When |
---|---|---|---|
$CABA MomentumIts now last up | crudeoil24 | investorshub | 05/13/2023 2:40:36 AM |
$CABA news out | Diggie-HH | investorshub | 04/25/2023 11:48:41 AM |
MomentumIts trading last up | TheFinalCD | investorshub | 04/21/2023 1:02:49 AM |
$CABA just the news we needed | crudeoil24 | investorshub | 04/20/2023 12:26:59 PM |
Great call! | Alan Brown | investorshub | 01/30/2023 12:49:45 PM |
Nice call here. | Laster | investorshub | 01/25/2023 3:31:52 PM |
Sold last week .85 to 8.75-$9.00 in less | TechandBio | investorshub | 12/26/2022 2:51:04 AM |
znewcar1: $CABA 26% v1,246M C6.81 f29,140M H7.30 ML.532 | znewcar1 | investorshangout | 12/15/2022 12:54:43 AM |
And now? | ollik78 | investorshub | 10/21/2022 5:46:16 AM |
https://twitter.com/Okame5208/status/1582912029345529856 | Hummingbird2 | investorshub | 10/20/2022 7:17:32 AM |
https://finance.yahoo.com/quote/$CABA?p=$CABA | Hummingbird2 | investorshub | 10/19/2022 8:14:16 AM |
https://www.cabalettabio.com/ | Hummingbird2 | investorshub | 10/19/2022 8:13:16 AM |
Awesome | Hummingbird2 | investorshub | 10/19/2022 8:11:49 AM |
Cabaletta Bio Announces $CABA-201, a Newly Designed CD19-Targeting | Mr. Zen | investorshub | 10/18/2022 12:03:20 PM |
Rumors? | Hummingbird2 | investorshub | 10/18/2022 2:41:09 AM |
https://finance.yahoo.com/news/iaso-biotherapeutics-cabaletta-bio-ink-140632788. | Hummingbird2 | investorshub | 10/17/2022 3:30:51 PM |
Rumors:: watch this one fly if true. | Mr. Zen | investorshub | 10/12/2022 2:26:37 AM |
Well that proved to be a huge mistake. | shajandr | investorshub | 09/06/2022 12:50:06 AM |
Oh wow that was luck I guess | europtiger | investorshub | 08/22/2022 6:38:47 PM |
Just got 1,67 hope no offering lol | europtiger | investorshub | 08/22/2022 6:38:18 PM |
News, Short Squeeze, Breakout and More Instantly...
PHILADELPHIA, July 02, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced that Steven Nichtb...
2024-06-20 09:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
– No CRS, ICANS, infections or serious adverse events observed in either of the first two patients through data cut-off of May 28, 2024 – – CABA-201 exhibited anticipated profile of CAR T cell expansion and contraction with complete B cell depletion observed in both...